Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 10,190 | 9,232 | 21,842 | 10,799 | 11,416 |
| Operating Income | -10,190 | -9,232 | -21,842 | -10,799 | -11,416 |
| Other Income | 572 | 183 | 1,509 | -1,538 | 701 |
| Pre-tax Income | -9,618 | -9,049 | -20,333 | -12,338 | -10,715 |
| Net Income Continuous | -9,618 | -9,049 | -20,333 | -12,338 | -10,715 |
| Net Income | $-9,618 | $-9,049 | $-20,333 | $-12,338 | $-10,715 |
| EPS Basic Total Ops | -0.28 | -0.31 | -0.78 | -0.53 | -0.45 |
| EPS Basic Continuous Ops | -0.28 | -0.31 | -0.78 | -0.53 | -0.44 |
| EPS Diluted Total Ops | -0.28 | -0.31 | -0.78 | -0.53 | -0.45 |
| EPS Diluted Continuous Ops | -0.28 | -0.31 | -0.78 | -0.53 | -0.44 |
| EBITDA(a) | $-10,130 | $-9,174 | $-21,794 | $-10,758 | $-11,381 |